Collagenases and cracks in the plaque

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3201-3203

  Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; COLLAGEN; COLLAGENASE; FIBRINOGEN; INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; CORONARY ARTERY THROMBOSIS; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TENSILE STRENGTH; THROMBOGENICITY; VASOSPASM;

ANIMALS; ATHEROSCLEROSIS; COLLAGENASES; HUMANS; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC;

EID: 84881223424     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67526     Document Type: Article

References (26)

1. Falk E, Nakano M, Benton JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J. 2013;34(10):719-728.
2. Libby P, Clinton SK. The role of macrophages in atherogenesis. Curr Opin Lipidol. 1993;4(5):355-363.
3. Galis Z, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75(1):181-189.
4. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94(6):2493-2503.
5. Sukhova GK, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999;99(19):2503-2509.
6. Herman MP, et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation. 2001;104(16):1899-1904.
7. Henney AM, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88(18):8154-8158.
8. Nikkari ST, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92(6):1393-1398.
9. Galis Z, Sukhova G, Kranzhöfer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92(2):402-406.
10. Fukumoto Y, et al. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. Circulation. 2004;110(14):1953-1959.
11. Deguchi JO, et al. Matrix metalloproteinase-13/ collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation. 2005;112(17):2708-2715.
12. Deguchi J, et al. Genetically engineered collagenase resistance promotes abdominal aortic aneurysm formation. Lab Invest. 2009;89(3):315-326.
13. Aikawa M, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998;97(24):2433-2444.
14. Fukumoto Y, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation. 2001;103(7):993-999.
15. Aikawa M, et al. Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation. 1999;100(11):1215-1222.
16. Aikawa M, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001;103(2):276-283.
17. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103(7):926-933.
18. Watanabe K, et al. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol. 2005;46(11):2022-2030.
19. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(8):1359-1366.
20. Schoenbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998;161(7):3340-3346.
21. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481-3488.
22. Dutta P, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487(7407):325-329.
23. Maldonado N, et al. A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am J Physiol Heart Circ Physiol. 2012;303(5):H619-H628.
24. Ehara S, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110(22):3424-3429.
25. Libby P. Mechanisms of the acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004-2013.
26. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155-2165.